Affiliation:
1. Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece
Abstract
Objective:
Olmesartan-induced enteropathy consists a syndrome that mimics celiac disease
both clinically and histologically. Cases of this entity have sporadically been reported since
2012 and are usually characterized by severe diarrhea and malabsorption, followed by significant
weight loss.
Case Report:
Herein, we report an uncommon case of this syndrome, where weight loss preceded
several months the onset of gastrointestinal symptoms.
Discussion and Conclusion:
Physicians should be aware of unexplained weight loss in patients taking
olmesartan, as prompt discontinuation of the drug may prevent the deleterious consequences of
malabsorption.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Pharmacology,Toxicology
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献